-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.Börse NasdaqISIN IE00BF3W0Q35
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
208.941.440 oder 197.000.000
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
44 oder 14 Mitarbeiter
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 1,13 USD +0,89%
Dir gefallen die Informationen zu Iterum Therapeutics PLC?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Dir gefallen die Informationen zu Iterum Therapeutics PLC?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Dir gefallen die Informationen zu Iterum Therapeutics PLC?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Dir gefallen die Informationen zu Iterum Therapeutics PLC?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
34 News & Informationen zur Iterum Therapeutics PLC Aktie
ITERUM ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Iterum Therapeutics plc and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Iterum Therapeutics plc in the United States… | August 7, 2021
ITRM ALERT: Investors with Substantial Losses Have Opportunity to Lead the Iterum Therapeutics plc Class Action Lawsuit
Robbins Geller Rudman & Dowd LLP announces that purchasers of Iterum Therapeutics plc securities between November 30, 2020 and July 23, 2021, inclusive have until October 4, 2021 to seek… | August 6, 2021
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Iterum Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Iterum Therapeutics plc for violations of §§10 and 20 of the… | August 6, 2021
Iterum Therapeutics to Provide Business Update and Report Second Quarter 2021 Financial Results on August 13, 2021
DUBLIN, Ireland and CHICAGO, Aug. 06, 2021 — Iterum Therapeutics plc , a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat… | August 6, 2021
Iterum Therapeutics To Provide Business Update And Report Second Quarter 2021 Financial Results On August 13, 2021
DUBLIN, Ireland and CHICAGO, Aug. 06, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company
Iterum Therapeutics : Pomerantz Law Firm Announces the Filing of a Class Action Against Iterum Therapeutics plc and Certain Officers – ITRM
NEW YORK, Aug. 5, 2021 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Iterum Therapeutics plc and certain of its officers. The class action,… | August 6, 2021
Summit Therapeutics : Acurx Pharmaceuticals Joins the Antimicrobials Working Group
WASHINGTON, Aug. 5, 2021 /PRNewswire/ — The Antimicrobials Working Group announced today the addition of Acurx Pharmaceuticals, Inc. to its coalition of companies with the mission to combat… | August 5, 2021
4 Hot Penny Stocks to Watch With High Volume in August
Best Penny Stocks to Watch As July Ends? 3 For Your List
Iterum Therapeutics PLC (ITRM) Loses 67.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Iterum Therapeutics PLC (ITRM) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
3 Penny Stocks on Robinhood to Watch if You Like Biotech
Iterum Drops as FDA Denies Approval for UTI Treatment
Iterum's oral sulopenem treatment candidate still needs more testing, the FDA said Monday.
Mid-Day Market Update: Crude Oil Down 1%; Xenetic Biosciences Shares Spike Higher
Midway through trading Monday, the Dow traded down 0.19% to 34,996.16 while the NASDAQ fell 0.07% to 14,827.27. The S&P also fell, dropping 0….
40 Stocks Moving in Monday's Pre-Market Session
Gainers Dynatronics Corporation (NASDAQ:DYNT) shares rose 73.6% to $2.24 in pre-market trading after gaining over 9% on Friday. NanoVibronix Inc…
Iterum Therapeutics Receives Complete Response Letter From U.S. Food And Drug Administration For Oral Sulopenem
DUBLIN, Ireland and CHICAGO, July 26, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical company
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was s…
Top Penny Stocks to Buy Next Week? 3 to Watch In Summer 2021
Are These Hot Penny Stocks Worth Buying Right Now? 7 For Your List
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iterum Therapeutics plc (ITRM)
/PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Iterum Therapeutics plc (“Iterum” or the “Company”) (NASDAQ: ITRM). Such…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Iterum Therapeutics Plc (ITRM)
NEW YORK, July 7, 2021 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Iterum Therapeutics plc (“Iterum” or the “Company”)
Biohaven Leaps After Posting $93M Sales for Migraine Drug
Biohaven's Nurtec was approved for migraine treatment in February 2020 and for prevention this past May. Q2 sales: $93 million.
Trending Reddit Penny Stocks to Buy Now? Take a Look At These 7
Advaxis Jumps on Deal to Be Bought by Biosight
Advaxis shares advanced after the company agreed to be purchased by peer biotech Biosight of Israel.
Iterum Therapeutics Stock: A Speculative Buy Despite Regulatory Risks (NASDAQ:ITRM)
Iterum Therapeutics faces uncertainty as the FDA has issued a letter seeking labeling clarification. Click here to see why this stock could be an excellent candidate for a swing play.
Iterum Therapeutics Analyst Remains Bullish Despite Concerns Over FDA Letter
A lack of clarity and final decision in the U.S. Food and Drug Administration's (FDA) recent letter to Iterum Therapeutics PLC (NASD…
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.44% By Investing.com
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.44%
Mid-Afternoon Market Update: Silver Rises 2%; Alector Shares Spike Higher
Toward the end of trading Friday, the Dow traded up 0.46% to 34,792.90 while the NASDAQ rose 0.67% to 14,619.12. The S&P also rose, gaining 0.66% to …
Futures Hover At Record High Ahead Of Payrolls, China Tumbles After Commiefest
ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero
Iterum Therapeutics Provides Regulatory Update
DUBLIN, Ireland and CHICAGO, July 01, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical company
Top Penny Stocks to Buy in July? 7 You May Not Know About
24 Stocks Moving in Monday's Pre-Market Session
Gainers Intellia Therapeutics, Inc. (NASDAQ:NTLA) rose 28.9% to $114.49 in pre-market trading. Intellia Therapeutics and Regeneron Pharmaceutica…
8 Penny Stocks to Watch Right Now As June Comes to an End
Iterum Therapeutics (ITRM) Investor Presentation – Slideshow (NASDAQ:ITRM)
The following slide deck was published by Iterum Therapeutics plc in conjunction with this event.
Iterum Therapeutics To Participate In H.C. Wainwright BioConnect Virtual Conference
DUBLIN, Ireland and CHICAGO, Jan. 06, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company